29/03/2026
La importancia de la salud de la boca
American researchers linked oral bacteria from your mouth to Alzheimer's plaques in brains
Every time you skip flossing, you might be doing something far more consequential than risking a cavity. Researchers at NYU College of Dentistry have published the strongest evidence yet that Porphyromonas gingivalis — the primary bacterium responsible for chronic gum disease — routinely invades the bloodstream through inflamed gum tissue and travels to the brain, where it produces toxic enzymes called gingipains that directly drive the formation of amyloid beta and tau — the two hallmark proteins of Alzheimer's disease. 🦠
The connection had been suspected since 2019 when gingipains were found in the brain tissue of Alzheimer's patients. The NYU team's 2025 research went further, using longitudinal data from 5,400 adults tracked for 22 years. They found that individuals with severe chronic periodontal disease had a 3.7-fold increased risk of developing Alzheimer's disease — independent of age, genetics, education, or any other known risk factor. The risk increased with disease duration and severity, suggesting a cumulative dose-response relationship.
Mechanistically, gingipains produced by P. gingivalis appear to cleave ApoE protein in the brain, promoting amyloid aggregation and simultaneously degrading tau-clearing enzymes. 🔬 When the NYU team administered a specific gingipain inhibitor drug to mice infected with P. gingivalis, brain amyloid deposition was reduced by 96% compared to untreated infected controls.
A gingipain inhibitor — COR388 — is currently in phase 2/3 clinical trials for mild-to-moderate Alzheimer's disease. This research elevates gum disease from a dental concern to a neurological emergency — and makes regular dental care the cheapest Alzheimer's prevention strategy in existence.
Source: NYU College of Dentistry, Science Advances, 2025